We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Kimberly-Clark (KMB) Misses on Q3 Earnings and Revenue
Read MoreHide Full Article
Kimberly-Clark Corporation (KMB - Free Report) is one of the leading players in several consumer product categories including diapers, paper goods, and female personal care. Kimberly-Clark regularly focuses on improving its products through innovation in order to remain competitive and drive growth.
Kimberly-Clark’s cost saving measures, regular innovations, growth initiatives and a strong international presence are strong pillars of the company and have been driving earnings for the past many quarters. However, Kimberly-Clark has been facing headwinds of late, which is driving down its share price. Sluggish organic sales growth, unfavorable currency and increased competition are eroding sales growth.
A few law firms have filed a shareholder class action lawsuit against the company and Halyard Health, Inc., which was spun out of Kimberly-Clark in Oct 2014, that they made false and misleading statements regarding surgical gowns and knowingly provided defective surgical gowns to U.S. workers amid the Ebola crisis. Due to this, investors are eagerly awaiting Kimberly-Clark’s earnings report.
Investors should also note the recent earnings estimate revisions for KMB, as the consensus estimate has remained unchanged over the past 30 days period. KMB has a mixed history in earnings season. KMB has delivered three positive and one negative surprise in the last four quarters, making for a positive average surprise of 1.16%.
Currently, KMB has a Zacks Rank #4 (Sell). You can seethe complete list of today’s Zacks #1 Rank stocks here. The Zacks Rank could definitely change following Kimberly-Clark’s earnings report which was just released. We have highlighted some of the key stats from this just-revealed announcement below:
Earnings: KMB misses on earnings. Our consensus called for EPS of $1.54, and the company posted adjusted EPS of $1.52 per share instead. Investors should note that these figures take out stock option expenses.
Revenue: KMB posted revenues of $4.594 billion, missing our consensus estimate of $4.724 billion.
Key Stats to Note: Organic sales were flat in the quarter, with a growth witnessed in developing and emerging markets. For 2016, the company has tightened its previously announced guidance, due to a challenging economic and competitive environment.
Stock Price: Shares declined 0.40% in pre-market trading.
Check back later for our full write up on this KMB earnings report later!
Confidential from Zacks
Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Kimberly-Clark (KMB) Misses on Q3 Earnings and Revenue
Kimberly-Clark Corporation (KMB - Free Report) is one of the leading players in several consumer product categories including diapers, paper goods, and female personal care. Kimberly-Clark regularly focuses on improving its products through innovation in order to remain competitive and drive growth.
Kimberly-Clark’s cost saving measures, regular innovations, growth initiatives and a strong international presence are strong pillars of the company and have been driving earnings for the past many quarters. However, Kimberly-Clark has been facing headwinds of late, which is driving down its share price. Sluggish organic sales growth, unfavorable currency and increased competition are eroding sales growth.
A few law firms have filed a shareholder class action lawsuit against the company and Halyard Health, Inc., which was spun out of Kimberly-Clark in Oct 2014, that they made false and misleading statements regarding surgical gowns and knowingly provided defective surgical gowns to U.S. workers amid the Ebola crisis. Due to this, investors are eagerly awaiting Kimberly-Clark’s earnings report.
Investors should also note the recent earnings estimate revisions for KMB, as the consensus estimate has remained unchanged over the past 30 days period. KMB has a mixed history in earnings season. KMB has delivered three positive and one negative surprise in the last four quarters, making for a positive average surprise of 1.16%.
Currently, KMB has a Zacks Rank #4 (Sell). You can seethe complete list of today’s Zacks #1 Rank stocks here. The Zacks Rank could definitely change following Kimberly-Clark’s earnings report which was just released. We have highlighted some of the key stats from this just-revealed announcement below:
Earnings: KMB misses on earnings. Our consensus called for EPS of $1.54, and the company posted adjusted EPS of $1.52 per share instead. Investors should note that these figures take out stock option expenses.
Revenue: KMB posted revenues of $4.594 billion, missing our consensus estimate of $4.724 billion.
Key Stats to Note: Organic sales were flat in the quarter, with a growth witnessed in developing and emerging markets. For 2016, the company has tightened its previously announced guidance, due to a challenging economic and competitive environment.
Stock Price: Shares declined 0.40% in pre-market trading.
Check back later for our full write up on this KMB earnings report later!
Confidential from Zacks
Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>